Back to CBRS Asset Hub
CBRS ALERT
-11.45% Snapshot Move
Last 24 Hours
7 Cited Sources

Cerebras Sits at Its IPO Price as Buy Ratings Meet a Lockup Unlock

Cerebras has round-tripped to its $185 IPO price, with the CBRS perp down 11.45% over 24h as the market keeps punishing the company's first earnings report. Revenue beat and full-year guidance went up, but a guided gross-margin drop to 38-41% has overwhelmed the print. The unusual part: the sell side is nearly unanimous in defending the stock, even as roughly 28 million insider shares unlock into the weakness.

CBRS Asset HubSnapshot Preserved Original Tweet
Publish-time Hyperliquid price chart for CBRS, showing a recorded -11.45% move over 24h.

Mover Brief

Wall Street Defends, the Tape Doesn't Listen

The setup around Cerebras is unusual. In the two sessions since its first earnings report as a public company, the sell side has closed ranks: Morgan Stanley raised its target to $273 from $250 and kept Overweight, Wedbush moved to $280, and the stock collected a wall of buy ratings — most of them framing the margin cut as conservative.

None of it has mattered. The CBRS perp is down 11.45% over 24h to $185.90, effectively a round-trip to the $185 IPO price from the May listing. When analysts raise targets into a 30%-plus drawdown and the tape keeps selling, the message is that the market cares more about near-term cash economics than the 2027 story.

The Margin Number That Did the Damage

Revenue was never the problem. Q1 came in near $193 million, up roughly 94% year over year, and full-year guidance went up, not down. The damage was a single line in the outlook: core gross margin guided to 36-38% in Q2 and 38-41% for the full year, down from 46.5% in Q1.

The cause is structural, not a demand miss. A data-center capacity crunch is forcing Cerebras to lease back equipment and build out its own footprint, a drag management pegged at 10-15 points this year. That leaves it well below Nvidia's mid-70s and AMD's mid-50s margins — exactly the comparison a freshly public AI name didn't want investors drawing. CEO Andrew Feldman pushed back, calling the reaction 'misunderstood' and arguing the company is beating the plan it laid out at IPO. The tape disagreed.

The Lockup Sitting on the Bid

There's a mechanical reason the bounce keeps failing at this level. Roughly 28 million Class A shares held by insiders became tradeable on the second day after earnings — fresh supply hitting the market in the exact window the stock round-tripped to its float. Feldman said the staggered unlock was designed to smooth the usual post-IPO cliff, but conceded he wasn't certain it would work.

For traders, the $185 IPO price is now the battleground: both an obvious psychological line and the level where early backers flip between in the money and underwater. The longer-term bull case still rests on the more than $20 billion OpenAI agreement and $24.6 billion backlog Cerebras carries — but backlog doesn't clear a lockup, and that's the near-term tension holding price at the floor.

Sources & Provenance

Citations below are preserved as structured Postgres source rows for this brief.

Citations Preserved

7

Reference links carried forward from the published mover record.

Original Signal

Open source tweet

Market Route

Direct route preserved for readers who want to inspect the tracked Hyperliquid market behind this archive entry.

Already onboarded? Open tracked market
  1. 1CNBC — Cerebras (CBRS) Q1 earnings reportcnbc.com
  2. 2SEC Form 8-K — Cerebras announces Q1 FY2026 financial resultssec.gov
  3. 3Benzinga — Cerebras Q1 2026 earnings call transcriptbenzinga.com
  4. 4Yahoo Finance — Cerebras margins below AI chip rivalsfinance.yahoo.com
  5. 5Investing.com — Feldman says investors misunderstood margin guidanceinvesting.com
  6. 6TheStreet — Morgan Stanley sets first-ever Cerebras price targetthestreet.com
  7. 7CoinCentral — Cerebras lands nine buy ratings at oncecoincentral.com

This content is for informational purposes only and does not constitute financial advice. Trading perpetual futures involves substantial risk of loss.

Trade CBRS on Hyperliquid

Use referral code HIPERWIRE for 4% off trading fees on your first $25M in volume.

Live Market Metrics

Monitor real-time open interest and funding for CBRS.

Open CBRS In Terminal Screener